Hjem › Parkinsons sygdom › Vermont
Parkinsons sygdom kliniske forsøg i Vermont
4 studier for Parkinsons sygdom søger deltagere på steder i Vermont.
Byer i Vermont
Officiel studietekst (engelsk)
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- University of Vermont, Burlington
RekruttererObservationsstudie
Alder 45 til 75 · Alle køn · Opdateret 4. sep. 2026 · NCT07330258A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of Vermont Medical Center, Burlington
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 3. sep. 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Vermont Medical Center, Burlington
RekruttererFase 3
Alder 45 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06944522Pyridostigmine for the Treatment of Constipation in Parkinson Disease
- University of Vermont Medical Center, Burlington
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. feb. 2026 · NCT05603715Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.